arsenic trioxide has been researched along with Fibrosarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YA; Chiu, HW; Ho, SY; Lin, JH; Wang, YJ | 1 |
An, S; Chung, HY; Han, CJ; Hong, SI; Jin, HO; Kwak, HJ; Lee, HC; Lee, JY; Lee, SH; Park, CM; Park, IC; Park, MJ; Rhee, CH; Woo, SH | 1 |
Brown, SL; Griffin, RJ; Kim, JH; Lew, YS; Song, CW | 1 |
3 other study(ies) available for arsenic trioxide and Fibrosarcoma
Article | Year |
---|---|
Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis.
Topics: Adult; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Neoplasm Transplantation; Oxides | 2010 |
Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Northern; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Electrophoretic Mobility Shift Assay; Fibrosarcoma; Humans; JNK Mitogen-Activated Protein Kinases; Luciferases; Matrix Metalloproteinase 2; Neoplasm Invasiveness; NF-kappa B; Oxides; p38 Mitogen-Activated Protein Kinases; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; Tissue Inhibitor of Metalloproteinases; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2005 |
Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biological Transport; Disease Models, Animal; Fibrosarcoma; Male; Metabolic Clearance Rate; Methylcholanthrene; Mice; Mice, Inbred BALB C; Necrosis; Oxides; Perfusion | 1999 |